Summary
- Current Price
- As of today, SRPT price is $16.78, unchanged in the most recent trading session on
- Current Price All-Time High
- SRPT price is currently -90.77% below its historical high of $181.83 set on
- Market Cap
- SRPT current market cap is $2B, down -0.49% year-over-year
- Revenue
- SRPT current annual revenue is $2.20B, up +15.58% year-over-year
- Next Earnings
- The next earnings release for SRPT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Sarepta Therapeutics, Inc. |
| Ticker | NASDAQ: SRPT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sarepta.com |
| Employees | 1,372 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $16.78 | |
| Price, 1D Change | 0.00% | |
| $2B | ||
| - | ||
| - | ||
| 2.03 | ||
| $2.20B | ||
| Revenue, 1Y Change | +15.58% | |
| -$7.13 | ||
| EPS, 1Y Change | -404.75% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:6 | |
| Next Split | N/A | N/A |
| Last Ticker Change | AVII | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$7.13 | ||
| EPS Estimate | $4.34 | N/A |
| EPS Est. Change | +160.85% | N/A |
| $2.20B | ||
| Revenue Estimate | $1.84B | N/A |
| Revenue Est. Change | -16.33% | N/A |
| Current Price | $16.78 | |
| Price Target | $20.00 | - |
| Price Tgt. Change | +19.19% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.02 | $2.34 | -41.82% | |
| -$1.99 | -$7.13 | -258.47% | |
| $4.34 | N/A | +160.85% | |
| $2.87 | N/A | +140.25% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.84B | $1.90B | +3.26% | |
| $2.14B | $2.20B | +2.88% | |
| $1.84B | N/A | -16.33% | |
| $1.39B | N/A | -36.72% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $16.78 | |
| $19.26 | ||
| $16.89 | ||
| $22.39 | ||
| $17.12 | ||
| -$0.35 | ||
| 2.03 | ||
| $0.91 | ||
| 51.21 | ||
| 57.78% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $2.20B | ||
| -$7.13 | ||
| $1.32B | ||
| 59.78% | ||
| -$657.77M | ||
| -29.92% | ||
| -$713.41M | ||
| -32.45% | ||
| -$615.87M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.90 | ||
| 2.32 | ||
| 1.48 | ||
| - | ||
| 4 | ||
| -1.03 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 0.90 | ||
| 1.16 | ||
| -5,952.44 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $1.14B | ||
| $939.65M | ||
| $3.35B | ||
| $2.54B | ||
| $2.21B | ||
| $1.10B | ||
| $1.04B | ||
| $11.20M | ||
| $280.84M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $2.91B | ||
| $1.97B | ||
| $884.13M | ||
| $0.00 | ||
| $58.47M | ||
| $0.00 | ||
| $11.19M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$222.54M | ||
| $69.64M | ||
| -$151.28M | ||
| $109.85M | ||
| -$332.39M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wolfe Research | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Citigroup | → | |
| Oppenheimer | → | |
| Mizuho | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
No data
Screeners with SRPT
FAQ
- What is the ticker symbol for Sarepta Therapeutics, Inc.?
- The ticker symbol for Sarepta Therapeutics, Inc. is NASDAQ:SRPT
- Does Sarepta Therapeutics, Inc. pay dividends?
- No, Sarepta Therapeutics, Inc. does not pay dividends
- What sector is Sarepta Therapeutics, Inc. in?
- Sarepta Therapeutics, Inc. is in the Healthcare sector
- What industry is Sarepta Therapeutics, Inc. in?
- Sarepta Therapeutics, Inc. is in the Biotechnology industry
- What country is Sarepta Therapeutics, Inc. based in?
- Sarepta Therapeutics, Inc. is headquartered in United States
- When did Sarepta Therapeutics, Inc. go public?
- Sarepta Therapeutics, Inc. initial public offering (IPO) was on June 4, 1997
- Is Sarepta Therapeutics, Inc. in the S&P 500?
- No, Sarepta Therapeutics, Inc. is not included in the S&P 500 index
- Is Sarepta Therapeutics, Inc. in the NASDAQ 100?
- No, Sarepta Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Sarepta Therapeutics, Inc. in the Dow Jones?
- No, Sarepta Therapeutics, Inc. is not included in the Dow Jones index
- When was Sarepta Therapeutics, Inc. last earnings report?
- Sarepta Therapeutics, Inc.'s most recent earnings report was on August 5, 2026
- When does Sarepta Therapeutics, Inc. report earnings?
- The next expected earnings date for Sarepta Therapeutics, Inc. is November 4, 2026
Data Sources & References
- SRPT Official Website www.sarepta.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/873303/000119312526084144/0001193125-26-084144-index.htm
- SRPT Profile on Yahoo Finance finance.yahoo.com/quote/SRPT
- SRPT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/srpt